Announcement on Obtaining Korea Pharmaceutical Raw Material Registration Certificate for Drug Substance Vonoprazan Fumarate by its Wholly-owned Subsidiary

About this update from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

Announcement on Obtaining Korea Pharmaceutical Raw Material Registration Certificate for Drug Substance Vonoprazan Fumarate by its Wholly-owned Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang East Asia Pharmaceutical Co., Ltd. Class A